Vivo Capital closes $100 mln healthcare VC fund
Vivo Capital closed the Vivo PANDA Fund, a new healthcare venture capital fund, at over $100 million. The firm intends to invest the new capital in early-state companies in sectors including pharmaceuticals, biotechnology, medical devices and diagnostics.
13 June 2016•1 min read
